Activated ras genes are often associated with human myeloid leukemias with a monocytic differentiated phenotype. To investigate the role of the activated ras gene in leukemogenesis, a myeloid nontumorigenic cell line (FDC-PI ) was infected with a selectable retroviral vector carrying the v-Ha-ras gene (H1 neo). Infected FDC-PI cells were not only tumorigenic, but also showed increased monocytic differentiation in vitro. Monocytic differentiation and tumorigenicity in vivo were correlated with several-fold increased UTATIONS at codon 12, 13, or 6 1 in the ras gene, M found in 10% of human tumors, result in locking the protein in the active guanosine triphosphate (GTP)-bound confirmation and transmission of an uncontrolled output signal. '3' Among hematopoietic malignancies, a high incidence (25% to 40%) of ras gene activation is found in acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS),'B~-~ in contrast to the lower frequencies (10% to 20%) reported for lymphoid malignan~ies.~.~-" Interestingly, a significantly higher incidence (36% to 56%) is found in AML classified as either myelomonocytic or mon~cytic,''-'~ and in MDS classified as chronic myelomonocytic leukemia.' '~~3 '~ These findings suggest a distinct positive correlation between ras gene activation and leukemias characterized by myelomonocytic differentiation.
M found in 10% of human tumors, result in locking the protein in the active guanosine triphosphate (GTP)-bound confirmation and transmission of an uncontrolled output signal. '3' Among hematopoietic malignancies, a high incidence (25% to 40%) of ras gene activation is found in acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS),'B~-~ in contrast to the lower frequencies (10% to 20%) reported for lymphoid malignan~ies.~.~-" Interestingly, a significantly higher incidence (36% to 56%) is found in AML classified as either myelomonocytic or mon~cytic,''-'~ and in MDS classified as chronic myelomonocytic leukemia.' '~~3 '~ These findings suggest a distinct positive correlation between ras gene activation and leukemias characterized by myelomonocytic differentiation.
In agreement with this correlation, our own studies with two murine retroviruses harboring the v-Hams oncogene have demonstrated a preferential induction of neoplasias of the macrophage lineage in infected mice.I6-I9 Although we have shown that in the case of the malignant histiocytosis sarcoma virus (MHSV), part ofthis specificity occurs by virtue of specific expression of viral control sequences in myeloid cell^,'^ this does not explain the preferential induction of macrophage/monocytic tumors in adult mice infected with other ras oncogenic retroviruses, including the Harvey murine sarcome virus (Ha-MuSV)I6 (J. Lohler, manuscript in preparation).
The present study was designed to determine if expression of the activated Ha-ras oncogene leads to the preferential induction of macrophage differentiation and/or to a block of differentiation in later stages of the monocytic lineage. In this report, we present results that support the contribution of both mechanisms to the increased incidence (targeting) of activated ras expression in monocytic malignancies.
MATERIALS AND METHODS
The murine myeloid precursor cell line FDC-PIZo was used in this study as a target ce!l of v-Ha-ras expression. Cells were maintained in modified Eagle's minimal essential medium (MEM) supplemented with 10% fetal calf serum (FCS) and Wehi3B(D-)-conditioned medium as a source of interleukin-3 (IL-3). Either psi-2 helper cell lines2' or RAT1 cells infected with a competent Friend murine leukemia virus (F-MuLV) (denoted as +N in text) transfected with the H lneo vector were used to produce pseudotyped vectors. The H lneo vector was constructed by inserting the splice donor and neoR sequences of the previously described M5neo vecto$2 downstream of the v-Ha-ras oncogene of the Ha-MuSV (clone Details of vector construction and es- tablishment of virus-producing cell lines have been published elsewhere" (S. Hibi, manuscript submitted). All fibroblast cell lines were maintained in MEM with 10% FCS. The virus producing cell line psi-2 mos-neoR no. 4, releasing a vector with only the n e 8 gene (M3neo), was used in negative control infections and has been described previously.22 DNA extraction and Southern analysis were performed using standard methods. Total RNA was isolated by the guanidine isothiocyanate procedure and examined by Northern analysis after denaturation of the RNA with formaldehyde and separation by agarose gel electrophoresis. DNA fragments containing either the v-Ha-ras or &actin sequences were labeled by the method of Feinberg and V~g e l s t e i n~~ and used for hybridization of Southern and Northern blots. The RNase protection assay was performed as previously described.2s
A quantity of 2 X IO6 cells were labeled for 2 hours in methionine-free MEM with 5% dialyzed FCS and 200 pCi/mL "S-methionine (New England Nuclear, Boston, MA) after a I-hour preincubation. Labeled cells were lyzed in a buffer containing 1% Triton X-100,0.05 mol/L Tris-HC1 (pH 8.0), 5 mmol/L MgClz, 0.1 mol/L NaCI, and 3 mmol/L phenylmethylsulfonyl fluoride. Trichloroacetic acid-precipitable proteins (5 X lo6 cpm) were immunoprecipitated with 200 pL hybridoma supernatant containing antibody (Y 13-259) to p2 1 or, as control, with normal rat IgG (Sigma, St Louis, MO) for 1 hour on ice. Protein A-Sepharose CL4B (Pharmacia Fine Chemicals, Uppsala, Sweden) coated with anti-rat IgG goat immunoglobulin (Sigma) was added and incubated on ice for another 2 hours with agitation. Precipitables were washed four times with a buffer of 0.05 mol/L HEPES (pH 7 . 9 , 0.1 mol/L NaCI, 1% Triton X-100,0.5% deoxycholate, 0.1% sodium dodecyl sulfate (SDS), and 0.001 mol/L EDTA, once with phosphate-buffered saline (PBS) UK) and recognize macrophage2* and myeloid antigens:' respectively. Affinity-purified and alkaline phosphatase-coupled F(ab'), fragments of mouse anti-rat IgG were from a commercial source (Jackson-Dianova, Hamburg, Germany). Alkaline phosphatase activity was visualized with naphthol AS-BI phosphate (Sigma) and hexazotized new fuchsine (Merck).
Histochemical demonstration of nonspecific esterase and acid phosphatase was performed with a-naphthyl butyrate and naphthol AS-BI phosphate, respectively, as substrates. Phagocytic capacity was tested as previously de~cribed.'~ Cytologic and histologic methods.
RESULTS

Infection of FDC-PI cells with a v-Ha-ras retroviral vector
induces diferentiation in the macrophage/monocyte lineage. FDC-P1 cells, which are arrested at the early myeloid precursor stage of differentiation, were infected with a retroviral vector containing either both the v-Ha-ras oncogene and ne# marker gene (Hlneo) orjust the ne# gene (M3neo). Infected cells were plated in semisolid cultures in the presence of G418 (1.5 mg/mL) and colonies were picked after 10 to 12 days of incubation and maintained in liquid cultures. No significant difference between cloning efficiencies of the Hlneo-and M3neo-infected cells(2.5 X respectively) was observed. However, a distinct morphological difference was observed between cultures derived from H 1 ne0 and 3.3 X infections (FHR clones) and control cultures, marked by varying degrees of adherently growing cells, characteristic of macrophage cultures. Immunocytochemical and cytochemical analysis for differentiation specific antigens and enzymes confirmed a distinct shift in monocytic differentiation in vHa-ras-infected cultures (Table 1 and Fig 1) as compared with either uninfected or control infected cultures.
A significant variation was seen in the extent of monocytic differentiation between v-Ha-ras cultures. No correlation between the presence of the replication-competent F-MuLV helper virus that was present in some virus preparations (FHR + N cultures, Table 1 ) and the differentiation shift was found.
However, Southern and Northern blot analysis demonstrated that Hlneo-infected cultures that did not show a marked monocytic phenotype had suffered complete or partial deletions ofthe ras gene within the viral construct (Fig 2) (termed FHRclones), whereas clones that expressed several macrophagespecific determinants contained and expressed the intact H 1 neo vector with the v-Ha-ras gene (termed FHR+ clones). The majority of the cell clones were of this latter type.
These results show that introduction and expression of the v-Ha-ras gene in FDC-PI cells induces monocytic differentiation. Significantly, the extent of differentiation was more pronounced in the first few weeks of culture and a less strongly differentiated phenotype, but still distinct to that of uninfected FDC-P 1 or FHR-cells, was observed over prolonged culture of the cells.
FDC-PI cells expressing the activated v-Ha-ras gene are tumorigenic in mice. To assess tumorigenicity of infected cells, we injected both FHR+ and FHR-clones into syngeneic mice. DBA/2 mice were inoculated subcutaneously with lo3 to 10' cells and tumor formation was monitored over 20 weeks ( Table 2) . No tumors were detected with either uninfected cells or cell clones infected with a control vector (FHR-cells). However, FDC-P1 cells that expressed the vHa-ras vector were highly tumorigenic. Approximately IO5 cells were sufficient to elicit tumors. Most of these tumors Histology of the FHR+ tumors showed a striking shift from the partially differentiated phenotype of the FHR+ cells cultured in vitro to a fully differentiated histiocytic phenotype. The subcutaneous tumors consisted of a relatively uniform and loosely attached cell population (Fig 3A) . The roundish to slightly polygonal tumor cells possessed ill-defined cell borders, a pale cytoplasm with numerous small acidophil granules, and round to oval, occasionally slightly indented, nuclei. Aggregated masses of granules could form intracytoplasmic inclusions. There were many mitoses (one to three per optical (Fig 3B through D) , and a positive histochemical reaction for nonspecific esterase and acid phosphatase (not shown). Taken together, these features are compatible with the morphological diagnosis of histiocytic sarcoma. tigen (C3bi receptor), which is specific for differentiated macrophages or granulocytes. In contrast, Mac 1 and F4/80 expression was uniformly positive and high in T-FHR clones (Table I) . Similarly. all tumor-passaged cell lines were strongly positive for the macrophage-specific enzyme markers, nonspecific esterase, and acid phosphatase, in contrast to the vHa-ras-infected parental clones that were only weakly positive for these markers of macrophage differentiation.
In summary, the cell lines derived from the FHR+-induced tumors were homogeneous and clearly reflected the histiocytic phenotype of the tumors. and although of FHR' origin, they expressed several macrophage-specific determinants not expressed in the parental FHR' cells.
Expression of' macrophage colon.v-stimulating.factor is nor induced in either FHR+ or T-FHR cell clones. The expression level of the macrophage colony-stimulating factor (M-CSF) receptor (c_fms) is correlated with the progression of differentiation in cells of the monocyte-macrophage lineage30.3' (U. Just and W. Ostertag, manuscript submitted). We therefore determined the steady-state levels of M-CSF receptor RNA by the sensitive RNase protection assay. To our surprise, neither FHR nor T-FHR cells showed detectable levels of c + m RNA (data not shown). In agreement with these results, we could detect no proliferative response to v-Ha-ras exprc.Ysion is posilive!,? correlated with the monocyte/macrophage diflerentiation statiis. We showed that the transfer of a v-Ha-ras vector into the myeloid precursor cell line FIX-PI induced monocytic differentiation. Moreover, tumors and tumor-derived cell lines obtained after in vivo passage of these FHR+ cell lines were even more differentiated and shared many features of normal mature macrophages. We therefore asked if a correlation could be found between levels of v-Ha-ras expression and in vivo tumorigenicity and increased monocytic differentiation. The transcript levels of v-Ha-ras in both FHR' and T-FHR cell lines were analyzed by Northern blot analysis (Fig 4) . Interestingly, a tentative correlation between ras levels and tumorigenicity was observed among the FHR cell lines. Cell lines that expressed high levels (eg, FHR+75) were more tumorigenic than those with lower levels of ras RNA (eg, FHR+49) ( Table 2) . However, much more significant was the uniformly large increase in both ras transcript and protein levels in all of the tumorpassaged cell lines with a more mature differentiated phenotype (Figs 4 and 5) . No alterations in the copy number of M-CSF. of inoculation, but also from metastatic tumor nodules in spleens and lymph nodes. All cell lines, irrespective of FMuLV helper virus, were shown to be of donor origin by Southern analysis of viral integration (data not shown).
Despite the FHR' origin, the T-FHR clones showed striking differences in differentiation determinants. The major cell fraction of each T-FHR cell line showed strong adherence throughout a 3-month culture period. Phagocytotic capacity, Even more significant differences were seen in expression either the H 1 neo provirus or the Ha-rus gene was observed in these cells as determined by Southern analysis (data not shown).
DISCUSSION
In this study, we wanted to test whether the expression of activated ras genes, as found in a large fraction of acute and chronic monocytic leukemias in humans, as well as in several oncogenic retroviruses in induced human leukemias, could specifically alter the differentiation status of myeloid precursor cells and whether a correlation could be found between differentiation status and tumorigenicity. The introduction of a v-Ha-rus expression vector into the myeloid precursor cell line FDC-PI resulted in the immediate induction of monocytic differentiation (Table I) , establishing a clear correlation between v-Ha-rus expression and late myeloid differentiation in these cells. However, prolonged culture of cells expressing the v-Hams vector resulted in a "reversion" to varying degrees of the differentiation status, such that long-term cultures only weakly expressed several of the macrophage-specific markers, although they remained distinctly more differentiated than the parental FDC-PI cells. This observation is most likely not explained mechanistically by differentiation reversion, but rather by selection of infected cells with a less differentiated phenotype that may have a selective advantage during in vitro culture. However, further analysis is required to distinguish between these possibilities. Not surprisingly, in view of the large number of published work on ras oncogenicity, v-Ha-rus vector-infected FDC-PI cells were tumorigenic in syngeneic mice in contrast to the parental FDC-PI cell. However, interestingly, tumorigenicity was strongly correlated with a more differentiated monocytic phenotype. Indeed, analysis of both tumors and tumor-derived cell lines showed the greatly upregulated expression of the Mac I determinants (C3bi receptor) (Table 2 ), known to be absent on myeloid precursor cells, but expressed in mature macrophages and granulocyte^.^^ Although a large spectrum of mature differentiation markers were expressed, these cells still had morphological characteristics of blast cells, including a high proliferation capacity. This observation is consistent with the differentiated phenotype observed in leukemias with monocytic characters (eg, M4 and M5).
In addition to the more differentiated status of the tumor cells, a large increase in v-Hams expression was observed, although no amplification of the gene was observed. Several possibilities exist to explain the increased ras expression and the differentiation status. First, the more mature monocytic differentiation stage of the tumor cells could be the result of spontaneous differentiation that may occur at a low frequency in these proliferating cells. Although such an event in vitro could possibly result in a selective disadvantage, as observed after in vitro infection, it could be envisaged that if spontaneous differentiation leads to an increase of v-Ha-rus expression and thus a "more transformed" phenotype than the pa- A second interpretation could be that the monocytic differentiation is directly induced by the ras gene expression. This could be part of the same induction observed in vitro. but due to increased ras expression and/or the more favorable environment in vivo, the differentiation process is further manifested. but still blocked. Increased ras expression could be the result of mutations within the viral or cellular genome that lead to an up-regulation of the LTR transcription. We are at present testing part of this prediction by rescue of virus from T-FHR cells. An obvious difference between the mi- croenvironment in vitro and in vivo is the concentration of the various hematopoietic growth factors that regulate granulocyte/macrophage differentiation and proliferation, in particular, the high levels of IL-3 needed to sustain the in vitro growth of the FHR cells is not present in vivo. Previous work has suggested that IL-3 may act to block differentiation in hematopoietic cell lines.35 Experiments in which IL-3 was removed from cultures of either FHR or T-FHR cells led to cell death and no signs of differentiation. Similarly, no cell differentiation was observed in the rare factor-independent variants that could be isolated when IL-3 was removed gradually. Interestingly, this phenotype was always correlated with low levels of endogenous expression of granulocyte-macrophage CSF (GM-CSF) (Hibi et al, submitted) . The use of stroma cells to mimic the in vivo environment may shed on the mechanism by which differentiation is manifested.
Although induction of differentiation by an activated ras gene has also been demonstrated in a limited number of other system^,^^.^^ there have also been several reports that link activated ras expression to a block in differentiati~n.~O-~* The survival of the differentiated T-FHR cells in vivo most likely also reflects a block in terminal differentiation. Whether this block can be directly attributed to ras expression or is an intrinsic characteristic of the FDC-P 1 cell line cannot be assessed. It could also be envisaged that the high proliferative capacity of the FHR-induced tumor cells may also be a direct consequence of elevated v-Hams expression, the signalling of which may interfere with normal terminal differentiation.
The mechanism of how v-Hams expression leads to differentiation in the monocytic lineage is obscure. These and other studies in which the response of FHR+ clones to different cytokines has been tested (Hibi et al, submitted) provide no evidence that differentiation induction by ras is linked with ligand/receptor interaction of known cytokines. Indeed, only negligible levels of M-CSF receptor expression were observed. Recent results have demonstrated the complete downregulation of M-CSF receptors by GM-CSp3; thus, this somewhat surprising observation may be attributed to low levels of GM-CSF expression induced by retroviral infection of FDC-P1 cells. The mechanism by which GM-CSF is induced by retroviral infection remains unclear, but is independent of ras expression. Alternatively to a direct action on ligand/receptor expression or interaction, activated ras expression may act by directly activating the molecules in the signal transduction pathway. Indeed several studies have shown that rus induces high levels of the transcription factors c-jun/AP-14*," and c -m y~,~~ both of which are implicated in myeloid differentiation and proliferation ~ignaIing.4~3~' Further clarification of the role of ras in signal transfer in myeloid precursor cells may help to explain our intriguing observation.
The results presented here demonstrate that activated ras expression can both induce monocytic differentiation of FDC-P 1 myeloid precursor cells and increase the survival of more mature monocytic cells after in vivo passage. Furthermore, we have found that activated v-Hams expression neither abrogates growth factor dependence nor leads to growth factor induction (Hibi et al, submitted) . Both sets of results are in accord with studies of human myeloid leukemias in which both factor dependence and a high correlation between the incidence of ras activation and a myelomonocytic phenotype have been described. The system described here thus provides a model system to study the causative role of activated ras expression in the progression of human myeloid leukemias.
